[{"address1": "100 Cambridgepark Drive", "address2": "Suite 101", "city": "Cambridge", "state": "MA", "zip": "02140", "country": "United States", "phone": "617 655 6580", "website": "https://www.vorbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 154, "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert  Ang M.B.A., M.D., MBBS", "age": 50, "title": "Strategic Advisor", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 994049, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jean-Paul  Kress M.D.", "age": 60, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Siddhartha  Mukherjee DPHIL, M.D., Ph.D.", "age": 54, "title": "Scientific Founder & Chairman of Scientific Advisory Board", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sandesh  Mahatme L.L.M.", "age": 60, "title": "Chief Business Officer & CFO", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Adi  Osovsky", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol  Lincoln CCP", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qing  Zuraw M.B.A., M.D., M.P.H.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallan  Murray", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Navid Z. Khan Ph.D.", "title": "Chief Medical Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeremy  Sokolove M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.08, "open": 13.2, "dayLow": 11.63, "dayHigh": 13.595, "regularMarketPreviousClose": 13.08, "regularMarketOpen": 13.2, "regularMarketDayLow": 11.63, "regularMarketDayHigh": 13.595, "payoutRatio": 0.0, "beta": 2.083, "forwardPE": -1.8668387, "volume": 1162413, "regularMarketVolume": 1162413, "averageVolume": 1657280, "averageVolume10days": 1087360, "averageDailyVolume10Day": 1087360, "bid": 11.93, "ask": 18.16, "bidSize": 2, "askSize": 2, "marketCap": 255039760, "fiftyTwoWeekLow": 2.62, "fiftyTwoWeekHigh": 65.8, "allTimeHigh": 1272.4, "allTimeLow": 2.62, "fiftyDayAverage": 14.3107, "twoHundredDayAverage": 22.357775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -46223268, "profitMargins": 0.0, "floatShares": 6981056, "sharesOutstanding": 21910630, "sharesShort": 1943561, "sharesShortPriorMonth": 294571, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0887, "heldPercentInsiders": 0.03561, "heldPercentInstitutions": 0.43791, "shortRatio": 0.62, "shortPercentOfFloat": 0.108100004, "impliedSharesOutstanding": 21910631, "bookValue": -246.539, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -2449551104, "trailingEps": -386.86, "forwardEps": -6.23514, "lastSplitFactor": "1:20", "lastSplitDate": 1758240000, "enterpriseToEbitda": 0.139, "52WeekChange": -0.6655172, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 11.64, "targetHighPrice": 55.0, "targetLowPrice": 32.0, "targetMeanPrice": 43.25, "targetMedianPrice": 43.0, "recommendationMean": 1.71429, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 170462000, "totalCashPerShare": 16.374, "ebitda": -333558016, "totalDebt": 3059000, "quickRatio": 9.048, "currentRatio": 9.156, "returnOnAssets": -1.44274, "freeCashflow": -183391376, "operatingCashflow": -143975008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "VOR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -11.0092, "regularMarketPrice": 11.64, "shortName": "Vor Biopharma Inc.", "longName": "Vor Biopharma Inc.", "marketState": "CLOSED", "postMarketTime": 1767401395, "regularMarketTime": 1767387601, "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_572078292", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekLowChangePercent": 3.4427483, "fiftyTwoWeekRange": "2.62 - 65.8", "fiftyTwoWeekHighChange": -54.160004, "fiftyTwoWeekHighChangePercent": -0.8231003, "fiftyTwoWeekChangePercent": -66.55172, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -386.86, "epsForward": -6.23514, "epsCurrentYear": -96.96598, "priceEpsCurrentYear": -0.1200421, "fiftyDayAverageChange": -2.6707, "fiftyDayAverageChangePercent": -0.18662259, "twoHundredDayAverageChange": -10.717774, "twoHundredDayAverageChangePercent": -0.47937572, "priceToBook": -0.047213625, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": -0.34364226, "postMarketPrice": 11.6, "postMarketChange": -0.03999996, "regularMarketChange": -1.44, "regularMarketDayRange": "11.63 - 13.595", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1657280, "fiftyTwoWeekLowChange": 9.02, "displayName": "Vor Biopharma", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]